Krebs Biochemicals & Industries has informed that the meeting of Board of Directors of the company is scheduled to be held on Friday, 11th January 2019 to consider and approve the record date, pricing, final letter of offer and other allied matters pertaining to the proposed Rights Issue; and any other matter with the permission of the Chair. Further, in connection to the above, trading window for dealing in shares of the company will remain closed for the specified persons as defined in the code from 7th January, 2019 and shall re-open on 15th January 2019 after the publication of outcome to the public.
The above information is a part of company’s filings submitted to BSE.
